Leman SKL Pharmaceuticals is a private, independent Swiss pharmaceutical company headquartered in Switzerland. With strategically located subsidiaries in Europe, Mexico, and Hong Kong, the company operates on a global scale, strengthening its international presence.
Leman SKL Pharmaceuticals originates from dermatology, excelling particularly through its European subsidiaries: Laboratoires Medgen SAS in France, based in Paris, and Leman SKL Srl in Italy, headquartered in Milan. Founded in 2020, these subsidiaries encompass the European Divisions of Dermatology, Gynecology, and OTC lines.
Building on this expertise, Leman SKL Pharmaceuticals has expanded its activities to develop medications across diverse therapeutic areas.
Leman SKL Pharmaceuticals develops and markets medications designed to improve patients’ quality of life in Switzerland and globally. All our medicines are approved by Swissmedic and European health authorities, meeting the needs of both hospital and outpatient care sectors.
The Leman SKL Pharmaceuticals Group is firmly established in Europe, with subsidiaries in Paris and Milan, and extends its reach internationally through strategic bases in Hong Kong and Mexico. From its headquarters in Switzerland, the company oversees its global operations, ensuring consistency and excellence across all its activities worldwide.
The company has plans for further expansion, aiming to enhance its international reach in the near future.
LABORATOIRES MEDGEN SAS
24 Rue Erlanger, 75016 Paris
FRANCE
LEMAN SKL SA
Route de Chancy 15,
1213 Petit-Lancy
SWITZERLAND
LEMAN SKL SRL
Largo Augusto 8
Milano 20122
ITALY
LEMAN SKL SRL DE CV
Londres 24-PISO 4
Col. Juárez, Cuauhtémoc,
C.P. 06600, Ciudad de México
MEXICO
LEMAN SKL LIMITED
21/F, On Hing Building,
1 On Hing Terrace, Central
HONG KONG
At Leman SKL Pharmaceuticals, we are dedicated to providing the most suitable healthcare solutions across various therapeutic areas. Our mission is to make healthcare accessible and affordable, improving lives and communities for as many people as possible.
Our patient-centered approach streamlines market access and ensures compliance with regulations, meeting the expectations of healthcare professionals and improving patient health on a global scale.
We focus on sustainable and responsible growth by building strong partnerships, enabling us to effectively address the needs of the healthcare sector.
Founded in 2019 in Geneva, the Leman SKL Pharmaceuticals Group is the culmination of 25 years of experience in the Life Sciences, spanning healthcare, pharmaceuticals, and cosmetics.
As a privately-owned pharmaceutical company, we enjoy significant flexibility in pursuing our mission to enhance the quality of life for patients worldwide.
Our product portfolio primarily consists of high-quality generic formulations and well-established products whose therapeutic benefits are widely recognized by healthcare professionals. This approach enables us to provide top-tier solutions tailored to the specific needs of our partners and the market.
While dermatology remains at the core of our development, Leman SKL Pharmaceuticals has expanded its expertise to include areas such as injectable antibiotics, anesthetics, anxiolytics, cardiovascular treatments, gastroenterology, gynecology, oncology, ENT, rheumatology, and urology.
Our ambition is to continue innovating and addressing therapeutic needs effectively and responsibly.
Shortage of injectable acetylsalicylic acid: Swissmedic authorizes Leman SKL to proceed with limited distribution of the French version of this essential medicine.
Be the first to discover our new treatments.
